Business
Earth Science Tech Initiates its Cannabis Cannabinoid-Based Composition of its 2 New Pharmaceutical Drugs and 3 Nutraceutical Patent Studies
Earth Science Tech Initiates its Cannabis Cannabinoid-Based Composition of its 2 New Pharmaceutical Drugs and 3 Nutraceutical Patent Studies.
About this update from Earth Science Tech, Inc.
[{"type":"text","content":"\n\n Hollywood, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) (\"ETST\" or \"the Company\"), an innovative biotech company focused on hemp cannabinoid research and development, has begun composition work on its two (2) new Cannabis Cannabinoid-Based pharmaceutical drugs and has initiated patent studies on its three (3) new nutraceutical products. This is the first project Earth Science Tech and its wholly owned subsidiary, Cannabis Therapeutics, are working with Smart Medicines GMP on as a result of the Company’s recently finalized joint venture.\n Earth Science Tech and Cannabis Therapeutics two (2) new Cannabis Cannabinoid-Based pharmaceutical drug formulations (compositions) are expected to be completed by summer 2017, with non-prescription nutraceuticals being available for sale before the end of the year and the pharmaceutical-grade products being launched in the first or second quarter of 2018. Earth Science Tech and Cannabis Therapeutics initial patent-pending Cannabinoid-Based nutraceutical product/products being developed seek to offer a broad spectrum of health protection, including immune system strengthening properties and strong antioxidant properties among a variety of other heath & overall wellness benefits. Another nutraceutical Cannabinoid-Based product in the pipeline seeks to improve and protect brain and liver function, which can improve the quality of life for patients, especially those experiencing harsh side effects from traditional medicines. The final nutraceutical to be developed is a prophylactic that aims to prevent some of the more common causes of cancer to help reduce occurrence rates. After the Company’s initial formulation work on the immune system-focused nutraceutical is finished, work will begin on a prescription depression, anxiety, and PTSD treatment. Once the mental illness drug formulation is finished, focus will be shifted toward developing a pharmaceutical-grade cancer treatment, with an emphasis on breast and brain cancers. Both of these pharmaceutical products will include CBD hemp oil and pure natural molecules, combined with generic drugs. Earth Science Tech and Cannabis Therapeutics look to offer patients the unique health benefits of CBD treatments with the proven backing of reliable, tried and true cancer and mental illness fighting dr...